Top NYC, NY Pharmaceutical Companies (91)
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. We are powered by technology. Our Global Research Technologies, Medical Devices as a software, and Data Science teams are on the cutting edge of developing and supporting our life-saving medications.
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
The challenges facing healthcare are multifaceted. While others place bets on discovering new drugs or mass-producing old ones that work well enough, we are different. We believe that by improving the way therapies are formulated and used we can have the biggest impact. Our heritage as a trusted pharmacy for Swiss hospitals taught us that even small changes can make big differences. Close cooperation with clinical experts still shapes our understanding of their unmet needs and our efforts to address them. With this trust and insight, we can push the limits of science and technology to make therapies safer, easier to use, and better for patients. At Sintetica, we continuously strive to improve therapies through innovative solutions driven by clinicians’ insights to meet patients' needs. Every year we reliably supply millions of doses of improved therapies across a range of therapeutic classes, including anesthesia and analgesia, while expanding to address unmet healthcare needs. At Sintetica, we continuously strive to improve therapies. In 2022, Sintetica took another important and significant step in its growth strategy as it established its subsidiary Sintetica US, headquartered in Princeton, New Jersey. Sintetica US is uniquely positioned with a strong core business, best in class research and development, high quality Swiss manufacturing, and a valuable pipeline. The company will bring a portfolio of innovative products to US customers and patients.
Organon is a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established medicines across a wide array of conditions and diseases. Our mission is to deliver impactful medicines and solutions for a healthier every day. This site is intended for residents of the United States and its territories. You are reminded to protect yourself against recruiting fraud from individuals, organizations or other entities claiming to represent Organon. All official Organon recruitment emails will come from accounts formatted as [email protected] or [email protected], and Organon will never conduct interviews by chat or email, or make job offers through social media or online forums. All candidates for roles at Organon will first meet with a recruiter and interview team, via Teams or in person. Organon will never ask you to make financial transactions on its behalf or ask you to receive or ship packages or goods. For more information on adverse event reporting, visit http://bit.ly/AEReporting. To read our community guidelines, visit http://bit.ly/OrganonCommunityGuidelines. Follow us on Twitter at Organon (@OrganonLLC). Follow us on Instagram at Organon (@OrganonLLC).
PRECISIONscientia, formerly ETHOS Health Communications, was founded in 2002 with the vision of translating the science of medicine into clinical benefit. Today, we continue to live and work by the same guiding principles that established our beliefs, shaped our culture, and influenced who we hire, and remind us of our commitment. Over the years, the mediums and channels have evolved, but our belief in the power of medicine and devotion to the highest level of accuracy and integrity remain unchanged. In 2018, PRECISIONscientia joined the Precision Value & Health network of Precision Medicine Group. All that precision comes together to offer expertise and guidance throughout the entire commercial lifecycle of a medical innovation.
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in more than 35 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world. We strive to be a trusted healthcare partner by driving growth in evolving areas of healthcare, while building upon our distribution, products, and solutions to meet customer needs.
Parachute is transforming the landscape of DME (durable medical equipment) and supplies ordering. We help clinicians, suppliers, and other key players in healthcare ensure that millions of patients per year receive critical medical equipment and supplies.
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf
Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes three offices in New Jersey and California that focus on drug discovery, product development, and commercialization. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth in North America relies on entrepreneurial team players who are willing to share their expertise and ideas in an environment that prioritizes innovation, diversity, integrity and “wa.” Each person plays a significant role in shaping the work we do and the results we deliver.
Evidence-based, accessible, and judgment-free approach to opioid use disorder—right in the privacy of your own home.
Established in 2005, Bioscript Group is formed from multiple, specialist businesses to support our global pharmaceutical clients; we draw on their multidisciplinary expertise to help navigate critical decisions at key points in the product lifecycle. Our scientific and strategic expertise help our clients make better decisions. We provide medical communication services, market access consulting and regulatory writing support with deep domain expertise to effectively navigate complex disease areas.
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. Review our social media community guidelines below: https://syndax.com/social-media-community-guidelines/
There are two Otsuka pharmaceutical industry companies in the U.S.: Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America. Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) clinically develops and registers innovative healthcare products on a global basis.
.jpeg)
At PatientPoint, we're transforming every doctor-patient interaction with cutting-edge, technology-driven solutions designed to improve health outcomes and quality of life. By delivering impactful, digital, in-office patient education at no cost to physicians across the country, we empower healthcare professionals to connect more meaningfully with their patients. Through partnerships with trusted healthcare brands like Pfizer, P&G, Sanofi, Merck, NatureMade, and Bristol Myers Squibb, we’re making a real difference. Our mission to empower better health guides everything we do, reaching over 750 million patient visits each year and driving healthier, longer lives for patients everywhere. From the top down, we operate within a culture of collaboration and open-minded thinking. We are in it to win it as a team working together, not competing with each other. Your thoughts and ideas are equally valued by leadership and your colleagues. Our employees embody our company values: they’re trustworthy, driven, innovative and welcoming of diversity. You’ll enjoy being part of our group. We’re always learning, and we encourage entrepreneurial thinking. We challenge the status quo and are open to new ideas from every corner of the organization. You can help make a difference in the healthcare industry by discovering groundbreaking solutions that provide value to patients, providers, and sponsors. As a company that is still growing and always evolving, we provide plenty of career and learning potential. Here, you’ll work to advance the industry, develop your career goals and be rewarded for your efforts. It’s all within reach, because playing a key part in our success will enhance yours. PatientPoint is the trusted and fully established leader in patient engagement platforms. Our employees are proud to include our name on their resumes. Joining us has definite advantages: stability, rewards and benefits, professional growth potential, plus the knowledge you are in the right place to do your best work.
With 25,000+ products, niche-focused reps, and the “in your door in twenty-four” promise, Dealmed is the leader along the eastern seaboard in medical & pharmaceutical supply distribution, providing better products at better prices faster so you can deliver better care. We help our customers re-imagine their supply chain by: ☑ Knowing when, how, what, and where you need your supplies through inventory monitoring and predictive replenishment ☑ Reducing costs throughout the supply chain through strategic hubs, aggressive pricing, integrated ordering, and other initiatives ☑ Understanding what product works best for which procedures ☑ Standardization across settings and locations ☑ Shipping 5,000+ orders per day in multiple units of measure WHAT MAKES DEALMED DIFFERENT? With an emphasis on domestically sourced products and sophisticated technology that integrates with clients’ PO systems, Dealmed gives you an edge to a better and healthier supply-chain. Combined with end-to-end solutions for warehousing, inventory, and distribution, our third-party logistics program is as seamless as any first-party operation. ☑ Exclusive Access: Leading Brands, Originals & Alternatives ☑ Rapid Access: Exclusive Contracts, GPOs & Tiered Pricing ☑ Priority Access: Manufacturers’ Backorders & Hard-to-Get Products CUSTOMERS Hospitals & Healthcare Systems | Physician Offices | Ambulatory Surgery Centers | Urgent & Community Health Care Centers | Dialysis Centers | EMS & First Responders | Government Agencies | Consumer & Specialty Markets SERVICES Medical Supply Distribution | Medical Equipment | Pharmaceuticals & Vaccines | Surgical Supplies & Equipment | Specialty Market Distribution | 3PL Services How can Dealmed help your business run profitably and stay ahead of whatever comes next? It starts by reimagining your supply chain. Contact a Dealmed sales rep: www.dealmed.com/register
At Verse, we're building software that enables hospital-quality care at home. We're freshly funded by top healthcare and technology investors, including Y Combinator, Abstract Ventures, Josh Buckley and Paul Graham (founder of Y Combinator). We're growing our team aggressively across every department. If you're interested in working on software that changes how healthcare is delivered, please reach out!
Formation Bio is a tech-driven pharma company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes all aspects of drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data capture. Formation Bio acquires clinical-stage drugs from pharma and biotech and develops them faster and more efficiently, unlocking greater value per program and accelerating access to new treatments for patients. Join our culture of innovation where your work directly contributes to transforming patient care in areas such as rheumatology, dermatology, CNS, and cardiometabolic diseases. Our dynamic environment blends advanced technology with strategic drug development, speeding up the delivery of new treatments. Here, every role plays a part in our mission to bring new treatments to patients faster and more efficiently.
At Diligent we connect clinical research sponsors, CROs, technology and service providers - quickly, efficiently and at very low risk. This can reduce the time taken to start clinical trials by up to 70 days. The cloud-based Diligent Qualification Platform holds comprehensive Request For Information (RFI) details for industry suppliers around the world, as well as Vendor Qualification Assessments (VQAs) audited against latest industry standards. This makes it easy for trial sponsors to identify and qualify relevant potential suppliers - much more quickly than by using traditional methods. It's also a great timesaver for industry suppliers as it cuts the number of RFIs to be completed and VQAs to host, while providers maintain 100% control over who sees their company information. With the Diligent Qualification Platform, industry vendors are more visible and easily accessible to organizations actively searching for partners to conduct clinical research. Meanwhile trial sponsors can take advantage of the most recent technologies on the market with an objective selection process based on verified and up to date supplier details
Taaneh is engaged in commercializing the use of diamond particles, an inert material for the authentication, identification and construction of anti-counterfeiting systems. The technology has applications in diverse sectors including the pharmaceutical industry (particularly solid oral dosage forms), prestige cosmetics and fragrances, foods, textiles, inks, currency, mechanical parts and packaging. Taaneh's IP and patent positions are designed to protect the technology that is the basis for the company's business plan.
Work Your Passion. Live Your Purpose.
